Annual Net Income
-$37.12 M
+$82.16 M+68.88%
31 December 2023
Summary:
ProShares UltraPro Short Nasdaq Biotechnology annual net profit is currently -$37.12 million, with the most recent change of +$82.16 million (+68.88%) on 31 December 2023. ZBIO annual net income is now at all-time high.ZBIO Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$38.61 M
-$629.00 K-1.66%
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology quarterly net profit is currently -$38.61 million, with the most recent change of -$629.00 thousand (-1.66%) on 30 September 2024. Over the past year, it has dropped by -$74.21 million (-208.42%). ZBIO quarterly net income is now -208.42% below its all-time high of $35.61 million, reached on 30 September 2023.ZBIO Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$128.97 M
-$74.21 M-135.54%
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology TTM net profit is currently -$128.97 million, with the most recent change of -$74.21 million (-135.54%) on 30 September 2024. Over the past year, it has dropped by -$164.58 million (-462.19%). ZBIO TTM net income is now -462.19% below its all-time high of $35.61 million, reached on 30 September 2023.ZBIO TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZBIO Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +68.9% | -208.4% | -462.2% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ZBIO Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +68.9% | -208.4% | at low | -462.2% | at low |
| 5 y | 5 years | at high | +68.9% | -208.4% | at low | -462.2% | at low |
| alltime | all time | at high | +68.9% | -208.4% | at low | -462.2% | at low |
ProShares UltraPro Short Nasdaq Biotechnology Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$38.61 M(+1.7%) | -$128.97 M(+135.5%) |
| June 2024 | - | -$37.98 M(+36.6%) | -$54.76 M(+226.3%) |
| Mar 2024 | - | -$27.80 M(+13.1%) | -$16.78 M(-252.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$37.12 M(-68.9%) | -$24.59 M(-169.0%) | $11.02 M(-69.0%) |
| Sept 2023 | - | $35.61 M | $35.61 M |
| Dec 2022 | -$119.28 M | - | - |
FAQ
- What is ProShares UltraPro Short Nasdaq Biotechnology annual net profit?
- What is the all time high annual net income for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology annual net income year-on-year change?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly net profit?
- What is the all time high quarterly net income for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly net income year-on-year change?
- What is ProShares UltraPro Short Nasdaq Biotechnology TTM net profit?
- What is the all time high TTM net income for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology TTM net income year-on-year change?
What is ProShares UltraPro Short Nasdaq Biotechnology annual net profit?
The current annual net income of ZBIO is -$37.12 M
What is the all time high annual net income for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high annual net profit is -$37.12 M
What is ProShares UltraPro Short Nasdaq Biotechnology annual net income year-on-year change?
Over the past year, ZBIO annual net profit has changed by +$82.16 M (+68.88%)
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly net profit?
The current quarterly net income of ZBIO is -$38.61 M
What is the all time high quarterly net income for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high quarterly net profit is $35.61 M
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly net income year-on-year change?
Over the past year, ZBIO quarterly net profit has changed by -$74.21 M (-208.42%)
What is ProShares UltraPro Short Nasdaq Biotechnology TTM net profit?
The current TTM net income of ZBIO is -$128.97 M
What is the all time high TTM net income for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high TTM net profit is $35.61 M
What is ProShares UltraPro Short Nasdaq Biotechnology TTM net income year-on-year change?
Over the past year, ZBIO TTM net profit has changed by -$164.58 M (-462.19%)